Evaluation of the Cerebral Edema in Children Having Diabetic Ketoacidosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

31 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-08-31

Study Completion Date

2017-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine cerebral edema with evaluation of measurement of diameter of optic nerve sheath.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Diabetic Ketoacidosis Diagnosis and Management

NCT06327737

Metabolic Acidosis Diabetic Ketoacidosis Brain Edema

COMPLETED

DKA Optic Ultrasound

NCT02130180

Diabetic Ketoacidosis Uncontrolled Type 1 Diabetes Mellitus

UNKNOWN

Diabetic Ketoacidosis: Brain Morphology and Cognition

NCT02443415

Diabetic Ketoacidosis

COMPLETED

Cardiovascular Disease Risk in Children With Type 1 Diabetes Mellitus

NCT06356051

Type 1 Diabetes

COMPLETED

Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement

NCT03490019

Bardet-Biedl Syndrome Visual Impairment

WITHDRAWN PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to determine cerebral edema with evaluation of measurement of diameter of optic nerve sheath. For that, If patients have Fluid treatment shall be started in 4 hours in our or other Emergency Care, they will be included our study. If not, they will be out of our study.

How we measure;

1. First measurement shall be taken in 4 hours.
2. Second measurement shall be taken at 12 hours in mild and 12-18 hours measurement shall be taken for severe diabetic ketoacidosis,
3. Third measurement shall be taken after fluid treatment.
4. Fourth measurement shall be taken at polyclinic control. So, after all measurements will be hand and all data will be analyzed with statistical program. After that all outcome will be discussed and compared with patient at normal conditions at their polyclinic visit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Edema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasonic Measurement

How we measure;

1. First measurement shall be taken in 4 hours.
2. Second measurement shall be taken at 12 hours in mild and 12-18 hours measurement shall be taken for severe diabetic ketoacidosis,
3. Third measurement shall be taken after fluid treatment.
4. Fourth measurement shall be taken at patients polyclinic control.

Intervention Type OTHER